MENU
News
CME
Journals
All Specialties
All Specialties
Aesthetics
Allergy/Immunology
Cardiac/Vascular Intervention
Cardiology
Dermatology
Endocrinology
Gastroenterology
Hematology/Oncology
Hepatology
Infectious Disease
Nephrology
Neurology
Ophthalmology
Optometry
Orthopedics
Pediatrics
Primary Care
Psychiatry
Pulmonology
Rheumatology
Ophthalmology
All Subspecialties
All Subspecialties
Cataract Surgery
Contact Lenses
Cornea/External Disease
Glaucoma
Imaging/Diagnostics
Neurosciences
Ocular Oncology
Oculoplastics
Ophthalmic Business
Optics
Pediatrics/Strabismus
Practice Management
Refractive Surgery
Regulatory/Legislative
Retina/Vitreous
Technology
Trauma
More
Resources
Meeting News
Opinion
Meeting Calendar
Current Issues
Healio Jobs
Account
Log Out
Log In
News
Search
News
CME
Journals
Log In
Log Out
All Specialties
All Specialties
Aesthetics
Allergy/Immunology
Cardiac/Vascular Intervention
Cardiology
Dermatology
Endocrinology
Gastroenterology
Hematology/Oncology
Hepatology
Infectious Disease
Nephrology
Neurology
Ophthalmology
Optometry
Orthopedics
Pediatrics
Primary Care
Psychiatry
Pulmonology
Rheumatology
All Subspecialties
All Subspecialties
Cataract Surgery
Contact Lenses
Cornea/External Disease
Glaucoma
Imaging/Diagnostics
Neurosciences
Ocular Oncology
Oculoplastics
Ophthalmic Business
Optics
Pediatrics/Strabismus
Practice Management
Refractive Surgery
Regulatory/Legislative
Retina/Vitreous
Technology
Trauma
Resources
Meeting News
Opinion
Meeting Calendar
Current Issues
Healio Jobs
Search
Healio
News
Ophthalmology
Current Issues
VIEW ISSUE
Ocular Surgery News U.S. Edition
Recently Posted
Strategies for sustained anti-VEGF delivery aimed at consistent dosing, durability
Eye banks, corneal surgeons tackle hand in hand evolving challenges of pandemic
Novel treatment aimed at dry eye
VIEW ISSUE
Ocular Surgery News APAO Edition
Recently Posted
Enspryng reduces risk, severity of relapse in neuromyelitis optica spectrum disorder
Orasis Pharmaceuticals raises $30 million in financing
Phase 2 trial of RGX-314 to treat wet AMD underway
VIEW ISSUE
Ocular Surgery News Europe Edition
Recently Posted
Beovu meets endpoints in phase 3 DME study
Enspryng reduces risk, severity of relapse in neuromyelitis optica spectrum disorder
Netildex gel meets primary endpoint
